Cardiomyopathy Clinical Trial
Official title:
Resistance and Aerobic Exercise for Subclinical Anthracycline Cardiomyopathy
This application proposes a prospective, single arm feasibility clinical trial of a 12-week
period of combined endurance and resistance training in survivors of childhood cancer who
were treated with doxorubicin and/or daunorubicin and have impaired cardiac function.
Baseline and post intervention imaging, laboratory, and neuropsychological evaluations will
be used to determine the effects of the intervention on body composition, serum lipid
profile, exercise tolerance, and neurocognitive functioning. Participants will be called
weekly to monitor compliance with the intervention. Incentives will be given at intervals
during the trial to optimize compliance with the intervention.
This study will evaluate the feasibility of a 12-week exercise intervention on the cardiac
function of survivors of childhood cancer treated with anthracyclines and known to have
cardiomyopathy.
As a secondary objective, the study will document the effect of a 12-week exercise
intervention on exercise tolerance, as determined by measurement of peak VO2 and peak
exercise workload, shortening fraction, ejection fraction, and left ventricular wall
thickness, and assess the impact of the intervention on neurocognitive functioning in
survivors of childhood cancer treated with anthracyclines and known to have cardiomyopathy.
;
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Supportive Care
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 | |
| Completed |
NCT02892448 -
Cardiac MRI for Metal on Metal Hip Resurfacing
|
N/A | |
| Active, not recruiting |
NCT02537782 -
Myocardial Work and Metabolism in CRT
|
N/A | |
| Completed |
NCT02525185 -
Contractile Reserve in Dyssynchrony: A Novel Principle to Identify Candidates for Cardiac Resynchronization Therapy
|
||
| Terminated |
NCT01705509 -
The Effects of Ranolazine on CPET Parameters in Ischemic Cardiomyopathy Patients (ERIC)
|
N/A | |
| Completed |
NCT00999947 -
Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy
|
N/A | |
| Completed |
NCT00626028 -
Comparison of Inhaled Nitric Oxide and Oxygen in Participants Reactivity During Acute Pulmonary Vasodilator Testing
|
Phase 3 | |
| Recruiting |
NCT00138931 -
Genetics of Cardiovascular and Neuromuscular Disease
|
||
| Withdrawn |
NCT02838355 -
Employing End Tidal Capnography in Continuous Flow Ventricular Assist Device Patients
|
N/A | |
| Completed |
NCT01085955 -
Investigation in Pregnancy Associate Cardiomyopathy
|
N/A | |
| Withdrawn |
NCT00428103 -
Effects of Mitral Valve Repair With the Geoform Ring on Cardiomyopathy
|
N/A | |
| Recruiting |
NCT00273637 -
Registry and Survey of Women With Pregnancy Related Cardiomyopathy
|
N/A | |
| Completed |
NCT00810550 -
Carotid Ultrasound in the Evaluation of Heart Failure
|
N/A | |
| Completed |
NCT04603521 -
Patients' Long-Term Survival of Obstructive Hypertrophic Cardiomyopathy (HCM)
|
||
| Enrolling by invitation |
NCT03057561 -
Efficacy of Dotarem® (Gd-DOTA) Versus Gadovist® (Gd-DO3A-butrol) for Late Gadolinium Enhancement Cardiac Magnetic Resonance
|
N/A | |
| Completed |
NCT00027170 -
Technical Development of Cardiovascular Magnetic Resonance Imaging
|
||
| Not yet recruiting |
NCT02917395 -
Evaluate the Efficacy of Disopyramide Therapy in Hypertrophic Obstructive Cardiomyopathy Patients
|
N/A | |
| Completed |
NCT02164721 -
Multicenter Automatic Defibrillator Implantation Trial - Chemotherapy-Induced Cardiomyopathy
|
N/A | |
| Completed |
NCT02331264 -
Cardiac Assessment of Patients With Hip Implants
|
N/A | |
| Completed |
NCT02270840 -
Budapest Upgrade CRT Study (Version 009-4.1)
|
N/A |